A phase I-II study of the histone deacetylase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Deacetylase Inhibitor

Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.598 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 598-598

Author(s):

Yifan Tu ◽

Dawn L. Hershman ◽

Christine M. Pellegrino ◽

Eleni Andreopoulou ◽

Della Makower ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

In regard to Kao et al.: Concomitant radiation therapy and paclitaxel for unresectable locally advanced breast cancer: Results from two consecutive Phase I/II trials (Int J Radiat Oncol Biol Phys 2005;61:1045–1053)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2005.06.045 ◽

2005 ◽

Vol 63 (4) ◽

pp. 1276 ◽

Cited By ~ 2

Author(s):

Silvia C. Formenti

Keyword(s):

Breast Cancer ◽

Radiation Therapy ◽

Phase I ◽

Advanced Breast Cancer ◽

Radiat Oncol Biol Phys ◽

Locally Advanced ◽

Advanced Breast ◽

Consecutive Phase

Weekly paclitaxel and cisplatin as neoadjuvant chemotherapy with locally advanced breast cancer: a prospective, single arm, phase II study

Oncotarget ◽

10.18632/oncotarget.17954 ◽

2017 ◽

Vol 8 (45) ◽

pp. 79305-79314 ◽

Cited By ~ 12

Author(s):

Liheng Zhou ◽

Shuguang Xu ◽

Wenjin Yin ◽

Yanpin Lin ◽

Yueyao Du ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3117 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3117-3117

Author(s):

F. J. Esteva ◽

T. L. Madden ◽

J. Lammey ◽

W. F. Symmans ◽

D. J. Booser ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Phase I and pharmacokinetic (PK) study of oblimersen, a proapoptotic Bcl-2 targeting oligonucleotide, in combination with doxorubicin and docetaxel in metastatic and locally advanced breast cancer (BC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3117 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3117-3117

Author(s):

F. J. Esteva ◽

T. L. Madden ◽

J. Lammey ◽

W. F. Symmans ◽

D. J. Booser ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Locally Advanced ◽

Erratum to: Investigation of ototoxicity of artesunate as add-on therapy in patients with metastatic or locally advanced breast cancer: new audiological results from a prospective, open, uncontrolled, monocentric phase I study

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-016-3023-9 ◽

2016 ◽

Vol 77 (6) ◽

pp. 1321-1321 ◽

Cited By ~ 2

Author(s):

Miriam König ◽

Cornelia von Hagens ◽

Sebastian Hoth ◽

Ingo Baumann ◽

Ingeborg Walter-Sack ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Phase I Study ◽

Locally Advanced ◽

Single Agent Weekly Paclitaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Feasibility Study

Clinical Oncology ◽

10.1016/j.clon.2011.09.012 ◽

2012 ◽

Vol 24 (9) ◽

pp. 604-609 ◽

Cited By ~ 3

Author(s):

S. Gupta ◽

R. Bharath ◽

T. Shet ◽

S.B. Desai ◽

V.M. Patil ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Advanced Breast Cancer ◽

Feasibility Study ◽

Single Agent ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel

P275 Platinum compounds (PLcs) added to standard adjuvant or neoadjuvant regimen of doxorubicin plus cyclophosphamide (AC), followed by weekly paclitaxel (wP) in triple negative (TN), HER 2-neu positive (HER 2+) or locally advanced breast cancer (LABC)

The Breast ◽

10.1016/s0960-9776(11)70217-x ◽

2011 ◽

Vol 20 ◽

pp. S66

Author(s):

M. Vassilaki ◽

A. Sioulas ◽

M. Tsantekidou ◽

A. Klitsa ◽

N. Desses ◽

...

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Triple Negative ◽

Locally Advanced ◽

Advanced Breast ◽

Weekly Paclitaxel ◽

Platinum Compounds ◽

Her 2

Why ACE—overview of the development of the subtype-selective histone deacetylase inhibitor chidamide in hormone receptor positive advanced breast cancer

Translational Breast Cancer Research ◽

10.21037/tbcr.2020.03.06 ◽

2020 ◽

Vol 1 ◽

pp. 5-5

Author(s):

Zhiqiang Ning

Keyword(s):

Breast Cancer ◽

Advanced Breast Cancer ◽

Histone Deacetylase ◽

Hormone Receptor ◽

Histone Deacetylase Inhibitor ◽

Advanced Breast ◽

Hormone Receptor Positive ◽

Deacetylase Inhibitor ◽

Subtype Selective

A phase I/II study of neoadjuvant liposomal doxorubicin, paclitaxel, and hyperthermia in locally advanced breast cancer

International Journal of Hyperthermia ◽

10.3109/02656731003639364 ◽

2010 ◽

Vol 26 (5) ◽

pp. 514-521 ◽

Cited By ~ 45

Author(s):

Zeljko Vujaskovic ◽

Dong W. Kim ◽

Ellen Jones ◽

Lan Lan ◽

Linda Mccall ◽

...

Keyword(s):

Breast Cancer ◽

Phase I ◽

Advanced Breast Cancer ◽

Liposomal Doxorubicin ◽

Locally Advanced ◽